Homo- and hetero-oligomerization of the c-Abl kinase and abelson-interactor-1

Cancer Research

Volumn 63, Issue 4, 2003, Pages 873-877

  Fan, Pang Dian ^a   Cong, Feng ^a   Goff, Stephen P ^a  

^a Columbia Univ Coll Phys/Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; ONCOPROTEIN; PROTEIN ABELSON INTERACTOR 1; PROTEIN TEL ABL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL STRAIN COS1; DIMERIZATION; EMBRYO; ENZYME ACTIVATION; ENZYME BINDING; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; OLIGOMERIZATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; EPITOPES; HOMEODOMAIN PROTEINS; HUMANS; MICE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-ABL; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 0037442431     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., Egerton, M., Shiloh, Y., Kharbanda, S., Kufe, D., and Lavin, M. F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature (Lond.), 387: 520-523, 1997.
2. Baskaran, R., Wood, L. D., Whitaker, L. L., Canmam, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., and Wang, J. Y. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation, Nature (Lond.). 387: 516-519, 1997.
3. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., and Pendergast, A. M. c-Abl is activated by growth factors and src family kinases and has a role in the cellular response to PDGF. Genes Dev., 13: 2400-2411, 1999.
4. Franz, W. M., Berger, P., and Wang, J. Y. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J., 8: 137-147, 1989.
5. Jackson, P., and Baltimore, D. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J., 8: 449-456, 1989.
6. Barila, D., and Superti-Furga, G. An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet., 18: 280-282, 1998.
7. Pluk, H., Dorey, K., and Superti-Furga, G. Autoinhibition of c-Abl. Cell, 108: 247-259, 2002.
8. Wen, S. T., and Van Etten, R. A. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev., 11: 2456-2467, 1997.
9. McWhirter, J. R., Galasso, D. L., and Wang, J. Y. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol., 13: 7587-7595, 1993.
10. McWhirter, J. R., and Wang, J. Y. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene, 15: 1625-1634, 1997.
11. Golub, T. R., Goga, A., Barker, G. F., Afar, D. E., McLaughlin, J., Bohlander, S. K., Rowley, J. D., Witte, O. N., and Gilliland, D. G. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol., 16: 4107-4116, 1996.
12. Okuda, K., D'Andrea, A., Etten, R. A., and Griffin, J. D. A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo. J. Clin. Investig., 100: 1708-1715, 1997.
13. Jackson, P., Baltimore, D., and Picard, D. Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants. EMBO J., 12: 2809-2819, 1993.
14. Smith, K. M., and Van Etten, R. A. Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization. J. Biol. Chem., 276: 24372-9, 2001.
15. Fan, P. D., and Goff, S. P. Abl interactor I binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases. Mol. Cell. Biol., 20: 7591-601, 2000.
16. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell, 103: 211-225, 2000.
17. Lewis, J. M., Baskaran, R., Taagepera, S., Schwartz, M. A., and Wang, J. Y. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA, 93: 15174-9, 1996.
18. Wen, S. T., Jackson, P. K., and Van Etten, R. A. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J., 15: 1583-1595, 1996.
19. Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y., and Hope, T. J. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl. Acad. Sci. USA, 95: 7457-7462, 1998.
20. Courtney, K. D., Grove, M., Vandongen, H., Vandongen, A., LaMantia, A. S., and Pendergast, A. M. Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol. Cell. Neurosci., 16: 244-257, 2000.
21. Stradal, T., Courtney, K. D., Rottner, K., Hahne, P., Small, J. V., and Pendergast, A. M. The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr. Biol., 11: 891-895, 2001.